Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH)

Human Pathology

Volumn 29, Issue 8, 1998, Pages 833-839

  Wilkens, Ludwig ^a   Tchinda, Joelle ^a   Burkhardt, Dagmar ^a   Nolte, Martina ^a   Werner, Martin ^a   Georgii, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CGH; Cytogenetics; FISH; Hematologic diseases

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOME; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; HYBRIDIZATION; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA;

EID: 0031904593     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90453-1     Document Type: Article

References (39)

1. Rowley JD: Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 27:122-136, 1990
2. Mitelman F: Catalog of Chromosome Aberrations in Cancer. New York, NY, Wiley-Liss, 1994
3. Bentz M, Huck K, du Manoir S, et al: Comparative genomic hybridisation in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 85:3610-3618, 1995
4. Heerema NA, Argyropoulos G, Weetman R, et al: Interphase in situ hybridization reveals minimal residual disease in early remission and return of the diagnostic clone in karyotypically normal relapse of acute lymphoblastic leukemia. Leukemia 7:537-543, 1993
5. Pinkel D, Straume T, Gray JW: Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A 83:2934-2938, 1986
6. Anastasi J, Le Beau MM, Vardiman JW, et al: Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridisation to interphase cells: A simple and sensitive method. Blood 79:1796-1801, 1992
7. Döhner H, Pohl S, Bulgay-Mörschel M, et al: Trisomy 12 in chronic lymphoid leukemias: A metaphase and interphase cytogenetic analysis. Leukemia 7:716, 1993
8. Kallioniemi A, Kallioniemi OP, Sudar D, et al: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 258:818-821, 1992
9. du Manoir S, Speicher MR, Joos S, et al: Detection of complete and partial chromosome gains and losses by comparative genomic hybridization. Hum Genet 90:590-610, 1993
10. Isola JI, Kallioniemi OP, Chu LW, et al: Genetic aberrations detected by comparative genomic hybridisation predict outcome in node negative breast cancer. Am J Pathol 147:905-911, 1995
11. Bryndorf T, Kichoff M, Rose H, et al: Comparative genomic hybridization in clinical cytogenetics. Am J Hum Genet 57:1211-1220, 1995
12. du Manoir S, Schröck E, Bentz M, et al: Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41, 1995
13. Nacheva E, Grace C, Holloway TL, et al: Comparative genomic hybridisation in acute myeloid leukemia. Cancer Genet Cytogenet 82:9-16, 1995
14. Benett JM, Catovsky D, Daniel MT, et al: Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group. Ann Intern Med 103:620-625, 1985
15. Georgii A, Buhr T, Buesche G, et al: Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leukemia and Lymphoma 22:15-29, 1996
16. Harris NL, Jaffe ES, Stein H, et al: Revised European American Classification of lympoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361-1392, 1994
17. Werner M, Kaloutsi V, Buhr T, et al: Cytogenetics of chronic myelogenous leukemia correlated to the histopathology of bone marrow biopsies. Ann Hematol 63:201-205, 1991
18. Mitelman F (ed): ISCN 1995: An international system for human cytogenetic nomenclature. Farmington, CT, Karger Publishers, 1995
19. Gosden CM, Davidson C, Robertson M: Lymphocyte culture, in Rooney DE, Czepulkowski BH (eds): human Cytogenetics: A Practical Approach. Oxford, UK, Oxford University Press, 1992, pp 31-54
20. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). New York, NY, Cold Spring Harbor Laboratory Press, 1989
21. Nolte M, Werner M, Ewig M, et al: Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for the detection of the 9;22 translocation. Leukoc Lymph 22:287-294, 1996
22. Ward BE, Gersen SL, Carelli MP, et al: Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: Clinical experience with 4,500 specimens. Am J Hum Genet 52:854-865, 1993
23. Fialkow PJ, Jacobson RJ, Papayannopoulou T: Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 63:125-130, 1977
24. Torlakovic E, Litz CE, McClure JS, et al: Direct detection of the Philadelphia chromosome in CD 20 positive lymphocytes in chronic myeloid leukaemia by tri-color immunophenotyping/FISH. Leukemia 8:1940-1943, 1994
25. Ried T, Baldini A, Rand TC, et al: Simultaneous visualization of seven different DNA probes using combinatorial fluorescence and digital imaging microscopy. Proc Natl Acad Sci U S A 89:1388-1392, 1992
26. Schröck E, du Manoir S, Veldman T, et al: Multicolor spectral karyotyping of human chromosomes. Science 273:494-497, 1996
27. Lundsteen C, Maahr J, Christensen B, et al: Image analysis in comparative genomic hybridization. Cytometry 19:42-50, 1995
28. Bartram CR: Molecular genetic aspects of myelodysplastic syndromes. Semin Hematol 33:139-149, 1996
29. Asimakopoulos FA, White NJ, White J, et al: Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood 84:3086-3094, 1994
30. Quintrell N, Lebo R, Varmus H, et al: Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells. Mol Cell Biol 7:2267-2275, 1987
31. Bristol A, Hall SM, Kritz RW, et al: Phospholipase C-148: Chromosomal location and deletion mapping of functional domains. Cold Spring Harbour Symp Quant Biol 53:915-920, 1988
32. Kunze N, Yang GC, Jiang ZY, et al: Localization of the active type I DNA topoisomerase gene on human chromosome 20q11.2-13.1 and two pseudogenes on chromosome 1q23-24 and 22q11.2-13.1. Hum Genet 84:6-10, 1989
33. Szpirer J, Szpirer C, Riviere M, et al: The interleukin-6-dependent DNA-binding protein gene (transcription factor 5: TCF5) maps to human chromosome 20 and rat chromosome 3, the IL 6 receptor locus (IL6R) to human chromosome 1 and rat chromosome 2, and the rat IL6 gene to rat chromosome 4. Genomics 10:539-546, 1991
34. Hendricks-Taylor LR, Bachinski LL, Siciliano MJ, et al: The CCAAT/ enhancer binding protein (C/EBP alpha) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP beta) gene (CEBPB) maps to human chromosome 20q13.1. Genomics 14:12-17, 1992
35. Brown-Shimer S, Johnson KA, Lawrence JB, et al: Molecular cloning and chromosome mapping of the human gene encoding protein phophotyrosyl phosphatase IB. Proc Natl Acad Sci U S A 87:5148-5152, 1990
36. Shannon KM, Turhan AG, Chang SS, et al: Familial bone marrow monosomy 7: Evidence that the predisposing locus is not on the long arm of chromosome 7. J Clin Invest 84:984-989, 1989
37. Dewald GW, Schad CR, Lilla VC, et al: Frequency and photographs of HGM 11 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms. Cancer Genet Cytogenet 68:60-69, 1993
38. Dewald GW, Wright PI: Chromosome abnormalities in the myeloproliferative disorders. Semin Oncol 22:341-354, 1996
39. Butturini A, Gale RP: Chronic myelogenous leukemia as a model of cancer development. Semin Oncol 22:374-379, 1996